| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 04/05/2005 | US6875436 Method for producing cell-fushion type morbillivirus mutants |
| 03/31/2005 | WO2005028658A2 Recombinant influenza vectors with a polii promoter and ribozymes |
| 03/31/2005 | WO2005028652A1 Nucleic acid and gene originating in novel hcv strain and replicon-replicating cell using the gene |
| 03/31/2005 | WO2005028643A1 Inactivation of non enveloped viruses |
| 03/31/2005 | WO2005027829A2 Method for vaccination of poultry by bacteriophage lysate |
| 03/31/2005 | WO2005027825A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 03/31/2005 | WO2004094466A3 Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 03/31/2005 | WO2003103605A3 Flexible vaccine assembly and vaccine delivery platform |
| 03/31/2005 | US20050070493 Methods and compositions for treating Parkinson's disease |
| 03/31/2005 | US20050070017 Adenoviral vaccine composition for use in prevention and treatment of viral infection; viricides; veterinary medicine |
| 03/31/2005 | US20050069870 Novel hepatitis C viral sequences for use as tool in detection, treatment and prevention of viral infection; immunotherapy; immunodiagnostics |
| 03/31/2005 | US20050069866 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 03/31/2005 | US20050069561 vaccine against Newcastle Disease contains one or more mutant immunogens of the NDW strain that lack the antigenic binding site on the F glycoprotein which is recognized by the monoclonal antibody mAb 54. |
| 03/31/2005 | US20050069534 Method of isolation and purification of trypsin from pronase protease and use thereof |
| 03/31/2005 | CA2539457A1 Nucleic acid and gene derived from novel hcv strain and replicon-replicating cell using said gene |
| 03/31/2005 | CA2537725A1 Method for vaccination of poultry by bacteriophage lysate |
| 03/31/2005 | CA2526834A1 Recombinant influenza vectors with a polii promoter and ribozymes |
| 03/31/2005 | CA2523657A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 03/30/2005 | EP1518933A1 Vectors and methods for gene transfer to cells |
| 03/30/2005 | EP1517987A2 Cotton rat lung cells for virus culture |
| 03/30/2005 | EP1203088B1 Conditionally controlled, attenuated hiv vaccine |
| 03/30/2005 | CN1602357A Novel phytases and method for producing these phytases |
| 03/30/2005 | CN1602353A Isolated phages and their use in food or pet food products |
| 03/30/2005 | CN1600852A Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup B |
| 03/30/2005 | CN1195057C Method for separating viral particles |
| 03/30/2005 | CN1195056C Recombined virus for specific proliferation and high efficiency expression of anti-cancer gene in tumor cells and its constitution method |
| 03/29/2005 | US6872561 Forming viruses |
| 03/29/2005 | US6872395 Viruses comprising mutant ion channel protein |
| 03/24/2005 | WO2005026378A2 Methods for gene function analysis |
| 03/24/2005 | WO2005026333A1 Technique for suspension culture of adhesive cells using protease and method of producing virus with the use of the cells as host |
| 03/24/2005 | WO2005026192A2 Hpv cd8+ t-cell epitopes |
| 03/24/2005 | WO2005025497A2 Hpv cd8+ t-cell epitopes |
| 03/24/2005 | WO2005007824A3 Mutants of vaccinia virus as oncolytic agents |
| 03/24/2005 | WO2003105875A8 Immunostimulator having antineoplastic action and method for producing said immunostimulator |
| 03/24/2005 | US20050066384 Using plasmid to enhance site-specific and/or homologous recombination between heterologous gene sequences and host nuclear DNA; tissue engineering and exogenous gene expression in plants |
| 03/24/2005 | US20050066382 Replication-defective retroviral vector for use as gene transfer and expression tool in avian transgenics; bioreactor and heterologous protein expression; tissue engineering |
| 03/24/2005 | US20050066380 Perv screening method and use thereof |
| 03/24/2005 | US20050064594 Transgenic liver cell for use as tool in diagnosis, prevention and treatment of viral diseases; viricides and receptor binding activity |
| 03/24/2005 | US20050064585 Apparatus comprising two endcapping sections and a hollow fibre filter for use in isolation and detection of microorganisms in fluids; hemodialysis membrane; calculating viral load |
| 03/24/2005 | US20050064394 Viral deletion mutant comprising nucleotide sequences associated with temperance factors for use as tool in detection of modulators which prevent and treat viral infection; viricides; genetic vaccines |
| 03/24/2005 | US20050064392 Expression vector comprising nucleotide sequences coding viral envelope proteins for use as tool in developing genetic vaccines to prevent, block and/or treat viral infection/disease |
| 03/24/2005 | US20050064389 Chimeric lyssavirus nucleic acids and polypeptides |
| 03/24/2005 | US20050063993 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |
| 03/24/2005 | US20050063957 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system |
| 03/24/2005 | US20050063954 Recombinant reovirus for treating a Ras-mediated proliferative disorder such as tumors |
| 03/24/2005 | CA2536735A1 Methods for determining cd8+ t-cell epitopes |
| 03/23/2005 | EP1516932A1 Poxvirus with targeted infection specificity |
| 03/23/2005 | EP1516058A2 Recombinant measles viruses expressing epitopes of antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| 03/23/2005 | EP1516055A2 Fiber shaft modifications for efficient targeting |
| 03/23/2005 | EP1181382B1 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 03/23/2005 | EP0981636B1 Lentivirus-based gene transfer vectors |
| 03/23/2005 | EP0968297B1 Live recombinant avian vaccine using the avian infectious laryngotracheitis virus as vector |
| 03/23/2005 | CN1599794A Production of viruses, viral isolates and vaccines |
| 03/23/2005 | CN1599623A Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 03/23/2005 | CN1597953A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 03/23/2005 | CN1597939A Multifunctional anticancer recombined adenovirus |
| 03/23/2005 | CN1597938A Recombined rhabdovirus containing double valence insect resisting gene |
| 03/23/2005 | CN1194091C Coton bollworm molt-regulating transcription factor cDNA and cloning method and recombination application thereof |
| 03/23/2005 | CN1193791C Ordered molecualr presentation of antigens. method of preparation and use |
| 03/22/2005 | US6870043 For broad use in therapy and prevention including antisense agents and vaccines |
| 03/22/2005 | US6869794 A packaging cell line capable of complementing recombinant adenoviruses based on serotypes from subgroup B, preferably adenovirus type 35. The cell line is preferably derived from primary, diploid human cells transformed by adenovirus E1 |
| 03/22/2005 | CA2127541C Recombinant swinepox virus |
| 03/19/2005 | CA2441723A1 Viral concentration process |
| 03/17/2005 | WO2005024039A2 Improved method for generating influenza viruses and vaccines |
| 03/17/2005 | WO2005024016A1 Mutant hsv vector useful in treating human glioma |
| 03/17/2005 | WO2005024005A1 Novel salmonella bacteriophage and uses thereof |
| 03/17/2005 | WO2005023849A2 Antigenic peptides of rabies virus and uses thereof |
| 03/17/2005 | WO2005023837A2 Ebola peptides and immunogenic compositions containing same |
| 03/17/2005 | WO2005023180A2 Method for detecting cancer cells and monitoring cancer therapy |
| 03/17/2005 | WO2005023010A2 Disinfection of foodstuffs |
| 03/17/2005 | WO2005002570A8 Use of an aziridino compound to selectively inactivate parasites in biological compositions |
| 03/17/2005 | WO2004101801A3 Improved method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding generic tools, as well as the applications of these non-pathogenic amplicons vectors |
| 03/17/2005 | WO2004076619A3 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 03/17/2005 | WO2004071324A3 Method to reduce, eliminate, or prevent bacterial pathogen colonization in eggs and/or poultry using bacteriophages |
| 03/17/2005 | WO2004022729A8 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 03/17/2005 | US20050059109 Methods and compositions for polypeptide engineering |
| 03/17/2005 | US20050058988 for identification and vaccination of human papillomavirus; |
| 03/17/2005 | US20050058987 Reverse genetics system for screening viricides; immunotherapy |
| 03/17/2005 | US20050058984 Novel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 03/17/2005 | US20050058664 Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant IBDV strains |
| 03/17/2005 | US20050058655 Vaccine and kit for viral disease in swine and diagnosis of diseases |
| 03/17/2005 | US20050058653 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
| 03/17/2005 | CA2545018A1 Disinfection of foodstuffs |
| 03/17/2005 | CA2537371A1 Antigenic peptides of rabies virus and uses thereof |
| 03/17/2005 | CA2535770A1 Method for detecting cancer cells and monitoring cancer therapy |
| 03/17/2005 | CA2517264A1 Ebola peptides and immunogenic compositions containing same |
| 03/16/2005 | EP1514937A1 Production of vaccines |
| 03/16/2005 | EP1513956A2 Assay to detect replication competent viruses |
| 03/16/2005 | EP1513930A1 Method for culturing hvc virus in vitro |
| 03/16/2005 | EP1513879A2 Synthetic antibody phage libraries |
| 03/16/2005 | EP1513872A1 INFECTIOUS cDNA OF AN APPROVED VACCINE STRAIN OF MEASLES VIRUS, USE FOR IMMUNOGENIC COMPOSITIONS |
| 03/16/2005 | EP1513552A1 Packaged virus-like particles for use as adjuvants: method of preparation and use |
| 03/16/2005 | EP1105495B1 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 03/16/2005 | CN1596126A 疫苗 Vaccine |
| 03/15/2005 | US6867033 By administration of PV virus-like particles (VLPs) to a patient suffering from the PV infection |
| 03/15/2005 | US6867022 Replication deficient adenovirus vectors and methods of making and using them |
| 03/15/2005 | US6866853 Engineering live attenuated viruses which contain a modified nonstructural gene segment; influenza vaccines |
| 03/15/2005 | US6866852 Expression vector coding genetically engineered F protein of newcastle disease virus for developing poultry vaccine |
| 03/10/2005 | WO2005020889A2 Functional influenza virus-like particles (vlps) |
| 03/10/2005 | WO2004104033A3 Viruses dependent on inducing agents for viral entry into a host cell |